Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Research & Development: 2019-2025

Historic Research & Development for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $71.7 million.

  • Burning Rock Biotech's Research & Development fell 31.92% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.5 million, marking a year-over-year decrease of 129.83%. This contributed to the annual value of -$31.8 million for FY2024, which is 34.89% up from last year.
  • Burning Rock Biotech's Research & Development amounted to $71.7 million in Q3 2025, which was up 184.72% from -$84.6 million recorded in Q2 2025.
  • Burning Rock Biotech's Research & Development's 5-year high stood at $259.9 million during Q4 2022, with a 5-year trough of -$109.4 million in Q3 2022.
  • Moreover, its 3-year median value for Research & Development was -$40.4 million (2025), whereas its average is -$4.8 million.
  • The largest annual percentage gain for Burning Rock Biotech's Research & Development in the last 5 years was 1,533.48% (2022), contrasted with its biggest fall of 906.93% (2022).
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Research & Development stood at -$18.1 million in 2021, then surged by 1,533.48% to $259.9 million in 2022, then decreased by 13.41% to $225.0 million in 2023, then crashed by 102.74% to -$6.2 million in 2024, then slumped by 31.92% to $71.7 million in 2025.
  • Its Research & Development stands at $71.7 million for Q3 2025, versus -$84.6 million for Q2 2025 and -$40.4 million for Q1 2025.